ENvue Medical, Inc. (FEED) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

ENvue Medical, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

ENvue Medical, Inc. (FEED) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.15 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-17

• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.15M shares, a 4911.32% increase year-over-year.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 22.95K shares, a 96.88% decline year-over-year.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 736.17K shares, a 234.00% increase year-over-year.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 220.41K shares, a 11.29% decline year-over-year.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.15M shares, a 3331.08% increase from fiscal 2024.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 33.52K shares, a 95.78% decline from fiscal 2023.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 795.08K shares, a 252.01% increase from fiscal 2022.
• ENvue Medical, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 225.87K shares, a 6.84% decline from fiscal 2021.